Pharmafile Logo
Pharmafocus logo
Advanced Search

Brammer Bio to set up new plant in Norton, Massachusetts

pharmafile | August 12, 2019 | News story | Sales and Marketing |  Brammer Bio, Massachusetts, US, norton, pharma 

Cambridge, Massachusetts-based Brammer Bio is planning to set up a new manufacturing facility in Norton, Massachusetts.

The Thermo Fisher subsidiary plans to employ 300 staff in its new Norton plant by 2021.

While the project is still in the preliminary stages, the cell and gene therapy firm plans to fund the new plant with tax increment financing (TIF), a public financing method used for redevelopment.

Advertisement

Brammer currently employs around 600 people in various locations, so will be increasing its stff by 50%.

In recent years Alnylam Pharmaceuticals also set up a $200 million plant in Norton’s industrial park.

Louis Goss

Related Content

Pharma sees climate disruption as growing supply-chain risk

Nine in ten pharmaceutical companies across the UK and G7 countries expect climate-related disruption to …

AI in pharma: From lab development to patient impact

In the decade to 2025, AI use in vaccine development has increased markedly but is …

Cell therapy partnership aims to bring liver disease treatment closer to US patients

Resolution Therapeutics has partnered with the Blood Centers of America (BCA) to support community-based delivery …

The Gateway to Local Adoption Series

Latest content

NIHR chief scientific adviser visits Huddersfield health innovation campus

September 25, 2026

One in three UK women with migraine say symptoms taken less seriously

September 24, 2026

Report highlights scope to expand day surgery

September 23, 2026

Sygnature formalises drug discovery collaboration with X-Chem

September 22, 2026

Codis appoints Steven Facer as chief commercial officer

September 21, 2026